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AbstrAct
Introduction: Current NHS guidelines require patients with suspected breast cancer to be seen urgently at a specialist breast 
clinic. The aim of this study was to assess referral patterns and clinical findings of patients referred to a specialist breast clinic.
Materials and Methods: A prospective database was maintained for consecutive patients referred. Symptoms and clinical 
findings in primary and secondary care were recorded.  Correlation with final diagnoses was made. Tertiary referral patients 
were excluded. 
results: 1098 patients attended a specialist breast clinic over six months. 588 (54%) were referred as urgent, 285 (26%) routinely 
and 225 (20%) were unspecified. 492 (45%) patients were referred with the incorrect referral priority. 42 patients were unexamined 
in primary care. Examination findings in primary and secondary care correlated in only 487 (46%) patients. Examination in primary 
care when compared with secondary care was highly sensitive for detecting breast lumps, but specificity was low. 86 patients 
(8%) were diagnosed with breast cancer, 72 (84%) were referred urgently, 6 (7%) routinely and 8 (9%) as unspecified priority.   
Regardless of the clinical expertise of the referrer, sensitivity and specificity of the two-week guidelines for cancer are low. 
conclusions: Examination findings in primary and secondary care correlate in only 46% of referrals. Additionally, 55% of 
referrals were of the correct priority. The two-week rule guidelines have poor sensitivity and specificity for cancer. The safest and 
fairest policy would be to abandon the concept of urgent referral criteria and see all patients in a timely fashion. Alternatively, 
simplifying the referral criteria would improve sensitivity and specificity for cancer without leading to increased waiting times.
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IntroductIon
Breast cancer is the most common malignancy among 
women with a lifetime risk of 11%.1 Over 45,000 women are 
diagnosed with breast cancer each year in the UK.2-5 Towards 
the end of the 20th century, UK survival rates for breast cancer 
were among the lowest in Europe, with long waiting lists for 
both diagnosis and treatment thought to be at least partly 
to blame.6-8 In 1998 the Department of Health attempted 
to address this problem in their circular, “Breast Cancer 
waiting times- achieving the two week target” with the aim to 
facilitate access to specialist services and ultimately improve 
survival.9 Despite the lack of strong scientific evidence this 
circular stated that, by April 1999, all patients with suspected 
breast cancer should be referred urgently to secondary care 
and seen by a specialist within two weeks of referral.10, 11
The effectiveness of two-week-wait guidelines for cancer 
in general and breast cancer in particular continues to be 
questioned. Of particular concern is the poor predictive 
value of symptoms and symptom clusters for cancer.12-14 
Additionally, there has been reluctance about switching 
responsibility for decision making regarding referral priority 
to the non-specialist.15, 16 General Practitioners (GPs) express 
concern about missing a cancer diagnosis and thus have 
a propensity to refer patients urgently, while specialists 
complain of the rule compromising their professional 
autonomy, report poor adherence to guidelines by primary 
care and patients with cancer referred outside the two-week-
rule experience much anxiety. 13,16
An increasing proportion of patients are referred urgently 
and while two-week targets are currently being met, a 
corresponding increase in waiting time for the routine group 
has been reported.12, 17 Most worryingly, the proportion of 
cancers detected in patients referred routinely also appears 
to be on the rise.12 
The Ulster Hospital Dundonald serves a population of over 
260,000 in Belfast and North County Down. It provides 
services for both secondary and tertiary referral and plays an 
important role in breast screening. Each year approximately 
300 new cases of cancer are diagnosed. At the time of data 
collection the breast care service included two consultant 
surgeons, one staff grade breast physician, two specialist 
registrars and three breast care nurses. The aim of this study © The Ulster Medical Society, 2011.
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was to compare clinical findings at the specialist breast clinic 
with those documented in primary care, examine adherence 
to referral criteria by primary care and analyse the two-week-
rule with regard to appropriate patient selection for cancer.
MAterIAls And Methods
Data were prospectively collected over a six-month 
period between 1st October 2006 and 31st March 2007. All 
consecutive referrals from primary care were included for 
analysis. Tertiary referrals, in-hospital referrals and screen-
detected cancers were excluded. Data collection sheets 
were completed for each patient attending the breast clinic. 
Assessment included information on patient demographics, 
referral priority, clinical findings and diagnosis. All patients 
referred urgently were seen within two weeks, and those 
referred routinely were seen within four weeks.
Referral priority and its accuracy in relation to two-week-
wait guidelines were examined while clinical findings in 
primary and secondary care were compared and correlated 
with final diagnoses. The predictive value of the two-week-
rule was evaluated. Age was expressed as mean and standard 
deviation. Data were collected on Microsoft Excel (Microsoft 
Corp, Redmond, WA, USA) and then analysed using SPSS 
(Version 12, SPSS Inc, Chicago, Il, USA). Differences in age 
group were analysed using Kruskal-Wallis and the difference 
in proportions using Chi-squared test, with a p value of less 
than 0.05 considered significant.
results
During the study period the Ulster Hospital Specialist Breast 
Service received 1098 referrals from primary care. The mean 
age at referral was 46.9 years (± 15.5) and at cancer diagnosis 
65 years (± 15.6). No patients were diagnosed with cancer 
under the age of 30 years. The risk of cancer, as expected, 
increased with age (p<0.0001) (Figure 1). 
There were disparities in clinical findings between the breast 
clinic and primary care. Examination findings in primary and 
secondary care were significantly different and correlated 
in only 487 (46%) patients (p<0.0001) (Table 1, Figure 2). 
Examination in primary care when compared with secondary 
care was highly sensitive for detecting breast lumps, but 
specificity was low. Forty-two patients were not examined 
in primary care with one cancer diagnosed in this group.  48 
(87%) of 55 patients with nipple discharge were referred as 
urgent, with no cancers in this group. It was not recorded 
if discharge was blood stained. No significant difference in 
accuracy of examination findings was found between different 
healthcare professionals in primary care, compared to the 
breast clinic.
588 (54%) patients were referred urgently, 285 (26%) 
routinely and 225 (20%) had an unspecified priority. 
According to documented symptoms and examination 
findings in primary care, 492 (45%) patients were referred 
with an incorrect referral priority; 141 (24%) urgent referrals 
did not fulfil the necessary criteria; 127 (56%) unspecified 
priority referrals and 126 (44%) routine referrals should have 
been referred urgently.  All those referred as urgent or routine 
were seen as such, with the unspecified priority referrals 
triaged on a daily basis by a Consultant Surgeon. The 127 
unspecified priority referrals which should have been referred 
urgently were seen within 2 weeks, meaning 715 patients were 
seen within 2 weeks of referral.
Seven hundred and eight (64%) patients referred had no 
identifiable breast pathology when seen in secondary care; 
330 had been referred urgently. 271 (25%) had benign breast 
problems, such as fibroadenomata and duct ectasia; 168 
were referred urgently. Eighty-six (8%) had cancer; 72 had 
been referred urgently, 6 routinely and 8 were of unspecified 
priority. Eighteen had other non-breast problems, ranging 
from eczema to sebaceous cysts.
Fig 1. The proportion of patients diagnosed with cancer for age 
group within the whole cohort.
Fig 2. Clinical examination findings in primary and secondary 
care (p<0.0001).
Table 1: 
Sensitivity and specificity of clinical examination in 
primary care compared with secondary care (To calculate 
GP sensitivity and specificity Breast Clinic findings were 
assumed to be both 100% specific and sensitive.)
Sensitivity (%) Specificity (%)
Lump 97 40
Discharge 36 48
Nodularity 24 70
Normal 31 35
Other 46 64
To calculate GP sensitivity and specificity Breast Clinic 
findings were assumed to be both 100% specific and sensitive.© The Ulster Medical Society, 2011.
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Strict application of current guidelines, based on the primary 
care clinical findings, would have increased the number of 
urgent referrals from 588 (54%) to 700 (64%), but decreased 
the number actually seen on an urgent basis from 715 to 700 
(p=0.77). Sensitivity for cancer would have improved from 
84% to 91%, while specificity would have decreased. If the 
breast clinic clinical findings had been used to refer patients 
according to current guidelines, the priority would have been 
markedly different, with only 307 (28%) referrals being 
classified as urgent (p<0.0001). Although specificity of the 
guidelines for cancer would improve when compared with 
primary care, sensitivity would only reach 86%, missing 14% 
of cancers (Table 2).
Data were analysed further to assess for any link between 
particular examination findings and cancer. Alteration of 
the guidelines (Figure 3) shows a trend towards improved 
sensitivity and specificity for cancer in primary care (Table 
2) (p=0.77). If breast clinic findings are used according to 
these proposed guidelines, sensitivity and specificity for 
cancer would improve significantly compared with primary 
care (p<0.0001).
dIscussIon
Since breast cancer is the commonest cancer among women 
in Europe, the UK government was justifiably concerned 
about the low survival rates in comparison to other western 
countries. The two-week-rule aimed to improve patient access 
to specialist services and allow rapid diagnosis and earlier 
treatment. Since its introduction the quality of both guidelines 
and referrals has been questioned. 
In this study, a large number of sub-optimal referrals were 
received, evidenced not only by the 225 referrals whose 
priority was unspecified, but also by the incorrect grading 
of referrals (45%). More than twice the number of patients 
who would have been referred urgently based on breast clinic 
findings were seen on an urgent basis, suggesting a tendency 
to refer urgently in primary care. This may, as other studies 
have suggested, be due to a decrease in diagnostic accuracy 
among general practitioners, concern about missing a cancer 
diagnosis or a lack of assurance in the referral guidelines.16, 18 
Moreover, patient anxiety may pressurise general practitioners 
into referring urgently.16
Clinical findings in primary and secondary care were often 
contradictory (54%). This can be explained by an expected 
lower level of clinical experience in primary care and perhaps 
uncertainty in declaring an examination to be normal.16 While 
there will remain to be room for improvement with regard to 
sensitivity and specificity of examination in primary care, 
specialist clinical examination applied to the two-week-wait 
criteria would also yield poor sensitivity and specificity for 
cancer. Non-urgent referrals would have included 12 (14%) 
cancers if breast clinic findings had been used to refer. Thus 
the main areas of concern with the current system lie with 
either the concept of urgent referrals or the referral guidelines 
themselves, rather than the clinical expertise of the referrer. 
As clinics have struggled to meet demands set by the two-
week-rule, patients referred routinely are being forced to 
wait longer for diagnosis and treatment, creating a two-tier 
referral system. Although our unit is committed to seeing 
routine referrals within 28 days, other institutions may have 
significantly longer waiting times.15 
While rapid access to specialist services is to be welcomed, 
Proposed Guidelines
Urgent Referrals
1.  Female >30years with
a.  A breast lump
b.  Asymmetric nodularity
2.  Male aged >50 years with a palpable unilateral 
swelling 
Fig 3. Proposed alternative two-week referral guidelines
Table 2: 
Number of urgent referrals, cancers referred urgently and sensitivity and specificity of current and proposed urgent referral 
guidelines for breast cancer.
Number of urgent 
referrals
Number of cancers 
referred urgently
Sensitivity Specificity
Current Guidelines
Actual GP Priority 588 72 84% 49%
GP priority + triaged referrals 715 79 91% 37%
According to two-week-rule by GP findings1 700 78 91% 39%
According to two-week-rule by BC findings2 307 74 86% 76%
Proposed Guidelines
By GP findings i.e. Current clinical expertise3 691 82 95% 32%
By BC findings i.e. Ideal clinical expertise4 395 85 99% 65%
Statistical significance 1 vs 2- p<0.0001; 3 vs 4- p=0.0004; 1 vs 3- p=0.77; 2 vs 4- p=0.58© The Ulster Medical Society, 2011.
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the current system would appear to be disadvantaging a 
significant proportion of patients with cancer.12,19,20 All 
patients with suspected breast malignancy experience high 
levels of anxiety and distress during the period leading up to 
their assessment and deserve to be seen promptly from both 
a psychological and oncological perspective.21
The safest and fairest policy would be to abandon the 
concept of urgent referral criteria and see all patients in a 
timely fashion. Several institutions have suggested seeing all 
patients within two-weeks of referral.12 This would require a 
dramatic increase in capacity and therefore funding to bring 
the backlog in the system up to date. While this may be an 
ideal scenario, ongoing budget cuts requiring efficiency 
savings make this option unlikely. Evidence has shown that 
significant differences in survival rates may only begin to 
become apparent after delays of over 3 months8 Therefore, we 
would suggest a maximum period of 4 weeks is reasonable 
from an oncological and psychological point of view, without 
compromise of patient safety or outcome. 
It is clear that government is committed to the principle of an 
urgent referral system and it is unlikely that the concept will 
be abandoned. An alternative would be to simplify the referral 
criteria (Figure 3), improving sensitivity and specificity for 
cancer without leading to a corresponding increase in urgent 
referral numbers, thus preventing diagnostic and treatment 
delay (Table 2). An improvement in clinical expertise in 
primary care would allow greater diagnostic confidence and 
reduce the referral of patients who do not need to be seen by 
a specialist. This would help reduce diagnostic and treatment 
delays for those who do need referred.
The authors have no conflict of interest.
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